PMID: 8595281Mar 2, 1996Paper

Serologically diagnosed infection with human papillomavirus type 16 and risk for subsequent development of cervical carcinoma: nested case-control study

BMJ : British Medical Journal
M LehtinenM Hakama

Abstract

To study human papillomavirus type 16 in the aetiology of cervical carcinoma. Within a cohort of 18814 Finnish women followed up to 23 years a nested case-control study was conducted based on serological diagnosis of past infection with human papillomavirus type 16. 72 women (27 with invasive carcinoma and 45 with in situ carcinoma) and 143 matched controls were identified during the follow up. Relative risk of cervical carcinoma in presence of IgG antibodies to human papillomavirus type 16. After adjustment for smoking and for antibodies to various other agents of sexually transmitted disease, such as herpes simplex virus type 2 and Chlamydia trachomatis, the only significant association was with infection with human papillomavirus type 16 (odds ratio 12.5; 95% confidence interval 2.7 to 57, 2P<0.001). This prospective study provides epidemiological evidence that infection with human papillomavirus type 16 confers an excess risk for subsequent development of cervical carcinoma.

References

Nov 22, 1991·Science·H zur Hausen
Oct 1, 1986·European Journal of Clinical Microbiology·M LehtinenJ Paavonen
Jun 16, 1993·Journal of the National Cancer Institute·M H SchiffmanS Wacholder

❮ Previous
Next ❯

Citations

Jul 20, 2010·Wiener medizinische Wochenschrift·Jan KlozarEva Hamšíková
Mar 1, 1997·Clinics in Dermatology·J J Carter, D A Galloway
Jul 12, 2003·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Harry W HaverkosWallace Pickworth
Aug 1, 1996·Current Opinion in Immunology·I H Frazer
Oct 1, 1996·Current Opinion in Immunology·R W Tindle
Nov 25, 2000·Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology·J Dillner
Nov 25, 2000·Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology·P L SternJ V Moore
Nov 25, 2000·Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology·J PaavonenM Lehtinen
Jun 22, 2001·Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology·M LehtinenM Hakama
Apr 12, 2001·The New England Journal of Medicine·J MorkJ Dillner
Jun 23, 2000·Clinical Obstetrics and Gynecology·R H KaufmanV Vonka
Mar 2, 1996·BMJ : British Medical Journal·J F HinesA B Jenson
Aug 6, 2004·Sexually Transmitted Infections·K A Fenton, C M Lowndes
Apr 8, 2011·Sexually Transmitted Infections·Matti LehtinenUNKNOWN FUTURE I and II Study Group
Jun 1, 1996·Genitourinary Medicine·I J Etherington, M I Shafi
Oct 1, 1996·Genitourinary Medicine·J D Ross
Apr 1, 1997·Genitourinary Medicine·J Paavonen
Aug 1, 1997·Genitourinary Medicine·J Green, A Kocsis
Dec 19, 2013·Archives of Gynecology and Obstetrics·Jani SilvaRui Medeiros
May 15, 2010·Future Oncology·Päivi LaukkanenMatti Lehtinen
Jul 18, 2014·Archives of Gynecology and Obstetrics·Shiyi CaoZuxun Lu
Sep 1, 2005·Women's Health·Jorma Paavonen, Matti Lehtinen
Sep 28, 2002·The Journal of Infectious Diseases·Jennifer S Smith, N Jamie Robinson
Oct 13, 2006·Current Opinion in Infectious Diseases·J Paavonen, M Lehtinen
Nov 27, 2002·Cancer Investigation·Mark H Einstein, Gary L Goldberg
Apr 11, 2008·Journal of the Formosan Medical Association = Taiwan Yi Zhi·Talia HooryT-C Wu
Jun 29, 2004·International Journal of Cancer. Journal International Du Cancer·Jennifer S SmithUNKNOWN IARC multicentric case-control study
Jan 24, 2012·The Journal of Adolescent Health : Official Publication of the Society for Adolescent Medicine·Sarah M TiggelaarJennifer S Smith
May 29, 2007·The Journal of Adolescent Health : Official Publication of the Society for Adolescent Medicine·Court PedersenUNKNOWN HPV Vaccine Adolescent Study Investigators Network
Mar 13, 2016·Life Sciences, Society and Policy·Raymond G De VriesScott Y H Kim
Mar 26, 2009·Journal of Medical Virology·Ruth TachezyEva Hamsíková
Feb 23, 2007·International Journal of Cancer. Journal International Du Cancer·C Sloane FurnissKarl T Kelsey
Dec 18, 2009·Journal of the European Academy of Dermatology and Venereology : JEADV·J Borges da CostaI Santo
Aug 8, 2013·International Journal of Cancer. Journal International Du Cancer·Helena FaustJoakim Dillner
Nov 16, 2004·Lancet·Matti Lehtinen, Jorma Paavonen

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.